Biblio

Export 242 results:
Author Title Type Year
Filters: First Letter Of Title is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Alzheimer Disease
J. Spiegel, Pirraglia, E., Osorio, R. S., Glodzik, L., Li, Y., Tsui, W., Louis, L. A. Saint, Randall, C., Butler, T., Xu, J., Zinkowski, R. P., Zetterberg, H., Fortea, J., Fossati, S., Wisniewski, T., Davies, P., Blennow, K., and de Leon, M. J., “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.
D. R. Royall, Palmer, R. F., Matsuoka, T., Kato, Y., Taniguchi, S., Ogawa, M., Fujimoto, H., Okamura, A., Shibata, K., Nakamura, K., Nakaaki, S., Koumi, H., Mimura, M., Fukui, K., and Narumoto, J., “Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data.”, J Alzheimers Dis, vol. 49, no. 2, pp. 571-9, 2016.
R. Weissmann, Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., and Wirths, O., “Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 397-409, 2016.
M. Bocchetta, Mega, A., Bernardi, L., Di Maria, E., Benussi, L., Binetti, G., Borroni, B., Colao, R., Di Fede, G., Fostinelli, S., Galimberti, D., Gennarelli, M., Ghidoni, R., Piaceri, I., Pievani, M., Porteri, C., Redaelli, V., Rossi, G., Suardi, S., Babiloni, C., Scarpini, E., Tagliavini, F., Padovani, A., Nacmias, B., Sorbi, S., Frisoni, G. B., and Bruni, A. C., “Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.”, J Alzheimers Dis, vol. 51, no. 1, pp. 277-91, 2016.
E. L. Paley, Merkulova-Rainon, T., Faynboym, A., Shestopalov, V. I., and Aksenoff, I., “Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1531-1540, 2018.
W. Zhang, Guo, Y., Li, B., Zhang, Q., Liu, J. - H., Gu, G. - J., Wang, J. - H., Bao, R. - K., Chen, Y. - J., and Xu, J. - R., “GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 807-819, 2018.
M. Guo, Peng, J., Huang, X., Xiao, L., Huang, F., and Zuo, Z., “Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 1, pp. 299-310, 2021.
D. Cuervo-Zanatta, Garcia-Mena, J., and Perez-Cruz, C., “Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S195-S214, 2021.
Amyloid beta-Peptides
G. He, Luo, W., Li, P., Remmers, C., Netzer, W. J., Hendrick, J., Bettayeb, K., Flajolet, M., Gorelick, F., Wennogle, L. P., and Greengard, P., “Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.”, Nature, vol. 467, no. 7311, pp. 95-8, 2010.
J. Spiegel, Pirraglia, E., Osorio, R. S., Glodzik, L., Li, Y., Tsui, W., Louis, L. A. Saint, Randall, C., Butler, T., Xu, J., Zinkowski, R. P., Zetterberg, H., Fortea, J., Fossati, S., Wisniewski, T., Davies, P., Blennow, K., and de Leon, M. J., “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.
S. Shi, Liang, D., Bao, M., Xie, Y., Xu, W., Wang, L., Wang, Z., and Qiao, Z., “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.
M. Bocchetta, Mega, A., Bernardi, L., Di Maria, E., Benussi, L., Binetti, G., Borroni, B., Colao, R., Di Fede, G., Fostinelli, S., Galimberti, D., Gennarelli, M., Ghidoni, R., Piaceri, I., Pievani, M., Porteri, C., Redaelli, V., Rossi, G., Suardi, S., Babiloni, C., Scarpini, E., Tagliavini, F., Padovani, A., Nacmias, B., Sorbi, S., Frisoni, G. B., and Bruni, A. C., “Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.”, J Alzheimers Dis, vol. 51, no. 1, pp. 277-91, 2016.
W. Zhang, Guo, Y., Li, B., Zhang, Q., Liu, J. - H., Gu, G. - J., Wang, J. - H., Bao, R. - K., Chen, Y. - J., and Xu, J. - R., “GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 807-819, 2018.
Amyloid beta-Protein Precursor
G. He, Luo, W., Li, P., Remmers, C., Netzer, W. J., Hendrick, J., Bettayeb, K., Flajolet, M., Gorelick, F., Wennogle, L. P., and Greengard, P., “Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.”, Nature, vol. 467, no. 7311, pp. 95-8, 2010.
R. Weissmann, Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., and Wirths, O., “Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 397-409, 2016.
Amyloid Precursor Protein Secretases
G. He, Luo, W., Li, P., Remmers, C., Netzer, W. J., Hendrick, J., Bettayeb, K., Flajolet, M., Gorelick, F., Wennogle, L. P., and Greengard, P., “Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.”, Nature, vol. 467, no. 7311, pp. 95-8, 2010.
Analysis of Variance
S. Shi, Liang, D., Bao, M., Xie, Y., Xu, W., Wang, L., Wang, Z., and Qiao, Z., “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.
Animals
G. He, Luo, W., Li, P., Remmers, C., Netzer, W. J., Hendrick, J., Bettayeb, K., Flajolet, M., Gorelick, F., Wennogle, L. P., and Greengard, P., “Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.”, Nature, vol. 467, no. 7311, pp. 95-8, 2010.
D. Chu, Tan, J., Xie, S., Jin, N., Yin, X., Gong, C. - X., Iqbal, K., and Liu, F., “GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.”, J Alzheimers Dis, vol. 49, no. 2, pp. 365-75, 2016.
R. Weissmann, Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., and Wirths, O., “Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 397-409, 2016.
S. Shi, Liang, D., Bao, M., Xie, Y., Xu, W., Wang, L., Wang, Z., and Qiao, Z., “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.
J. Mehla, Lacoursiere, S., Stuart, E., McDonald, R. J., and Mohajerani, M. H., “Gradual Cerebral Hypoperfusion Impairs Fear Conditioning and Object Recognition Learning and Memory in Mice: Potential Roles of Neurodegeneration and Cholinergic Dysfunction.”, J Alzheimers Dis, vol. 61, no. 1, pp. 283-293, 2018.
W. Zhang, Guo, Y., Li, B., Zhang, Q., Liu, J. - H., Gu, G. - J., Wang, J. - H., Bao, R. - K., Chen, Y. - J., and Xu, J. - R., “GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 807-819, 2018.
D. Cuervo-Zanatta, Garcia-Mena, J., and Perez-Cruz, C., “Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S195-S214, 2021.
Anti-Bacterial Agents
E. L. Paley, Merkulova-Rainon, T., Faynboym, A., Shestopalov, V. I., and Aksenoff, I., “Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1531-1540, 2018.

Pages